Premium
Induction of labor with prostaglandin E2 vaginal tablets in parous and grandmultiparous patients with previous cesarean section
Author(s) -
Sobande A.A.,
Albar H.
Publication year - 2002
Publication title -
international journal of gynecology and obstetrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.895
H-Index - 97
eISSN - 1879-3479
pISSN - 0020-7292
DOI - 10.1016/s0020-7292(02)00104-2
Subject(s) - medicine , parity (physics) , obstetrics , prostaglandin e2 , gynecology , prostaglandin , gestation , uterus , labor induction , vaginal delivery , pregnancy , oxytocin , endocrinology , biology , physics , particle physics , genetics
Objectives: To compare the outcome of induction of labor with prostaglandin E2 vaginal tablets between lower parity (parity 1–5) and grandmultiparous (parity >5) patients with a history of one previous lower segment cesarean section. Methods: A prospective study of 113 patients conducted at King Faisal Military Hospital, Khamis Mushayt, Saudi Arabia during a 5‐year period spanning January1995 to December 1999. Results: There were no statistically significant differences in the two groups regarding mean maternal age, dose of prostaglandin used, gestation at delivery, mean birth weight, P >0.05. Syntocinon augmentation was used in 16 (21.9%) of the lower parity patients compared with 8 (20.0%) in the grandmultiparas but this was not statistically significant, ( P =0.677). However, there was a statistically significant difference in the cesarean section rate between the two groups, P =0.019. Although no cases of uterine hyperstimulation were recorded, there was one rupture of the uterus in each of the two groups of patients; 1.36% and 2.5%, respectively, but this was not statistically significant, P =1.000. Conclusions: The complications of induction of labor with prostaglandin E2 vaginal tablets in grandmultiparous patients with previous cesarean section were similar to those with lower parity but the cesarean section rate was significantly higher. However, larger studies are needed for validation.